EOM PHARMACEUTICAL HLDNGS (IMUC) Debt by Year
EOM PHARMACEUTICAL HLDNGS carried $0 in long-term debt against $6.6M in cash and equivalents at the end of fiscal year 2017. This represents a decrease of 100.0% from the prior fiscal year. The table below carries 13 fiscal years, from 2005 to 2017, and the quarters EOM PHARMACEUTICAL HLDNGS has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMUC Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K | FY0810-K | FY0710-K | FY0610-K | FY0510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $0-100.0% | $6.9M+68.0% | $4.1M | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $6.6M-42.0% | $11.4M-49.4% | $22.6M-2.7% | $23.2M-16.0% | $27.6M+5.5% | $26.2M+294.0% | $6.7M+25.1% | $5.3M+1505.5% | $331K+288.5% | $85K | N/A | N/A | N/A |
IMUC Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'1810-Q | Q1'1810-Q | Q4'1710-Q | Q3'1710-Q | Q2'1710-Q | Q1'1710-Q | Q4'1610-K | Q3'1610-Q | Q2'1610-Q | Q1'1610-Q | Q4'1510-K | Q3'1510-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | $0-100.0% | $0-100.0% | $0-100.0% | $7.4M+68.2% | $6.9M+68.0% | $6.5M | $4.7M | $4.4M | $4.1M | N/A |
| Cash & Equivalents | $2.9M+57.3% | $5.0M-5.9% | $6.6M-42.0% | $6.0M-60.7% | $1.8M-84.8% | $5.3M-69.5% | $11.4M-49.4% | $15.3M-37.4% | $11.9M-61.3% | $17.5M-49.6% | $22.6M-2.7% | $24.4M+3.9% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More EOM PHARMACEUTICAL HLDNGS financials
Frequently Asked Questions
What was EOM PHARMACEUTICAL HLDNGS's long-term debt in fiscal year 2017?
EOM PHARMACEUTICAL HLDNGS carried $0 in long-term debt against $6.6M in cash and equivalents at the end of fiscal year 2017.
How fast is EOM PHARMACEUTICAL HLDNGS's long-term debt growing?
EOM PHARMACEUTICAL HLDNGS (IMUC) long-term debt fell by 100.0% year over year, from $6.9M to $0 in fiscal year 2017.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what EOM PHARMACEUTICAL HLDNGS (IMUC) reported on that line in every period on record.